AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-856 Cr | ₹-288 Cr | ₹122 Cr | ₹122 Cr | ₹128 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-856 Cr |
Mar2023 | ₹-288 Cr |
Mar2022 | ₹122 Cr |
Mar2021 | ₹122 Cr |
Mar2020 | ₹128 Cr |
How is Deferred Tax Assets / Liabilities of AUROBINDO PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-856 Cr | Negative | |
Mar2023 | ₹-288 Cr | Negative | |
Mar2022 | ₹122 Cr | 0.40 | |
Mar2021 | ₹122 Cr | -5.14 | |
Mar2020 | ₹128 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹64,439.8 Cr | -4.4% | -8% | -8.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,614.0 Cr | -2.5% | -4.7% | 11.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,533.0 Cr | -2.7% | -0.7% | 50.4% | Stock Analytics | |
CIPLA | ₹121,439.0 Cr | -1.2% | 0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,076.0 Cr | -2.3% | 8.2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,066.0 Cr | 1.4% | -1.5% | 13.3% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -4.4% |
-8% |
-8.3% |
SENSEX | -1% |
-0.9% |
6.7% |
You may also like the below Video Courses